T1	PROC 1 12	Tratamiento
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	CHEM 17 51	eritropoyetina recombinante humana
#2	AnnotatorNotes T2	C0376541; Recombinant Erythropoietin; Amino Acid, Peptide, or Protein · Pharmacologic Substance (?)
T3	DISO 53 86	hipertrofia ventricular izquierda
#3	AnnotatorNotes T3	C0149721; Left Ventricular Hypertrophy; Disease or Syndrome
T4	DISO 145 157	anemia renal
#4	AnnotatorNotes T4	C1142276; Renal anemia; Disease or Syndrome
T5	DISO 177 201	enfermedad renal crónica
#5	AnnotatorNotes T5	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T6	PROC 227 238	tratamiento
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	CHEM 324 335	hemoglobina
#7	AnnotatorNotes T7	C0019046; Hemoglobin; Amino Acid, Peptide, or Protein · Biologically Active Substance
T8	ANAT 390 399	cardíacas
#8	AnnotatorNotes T8	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T9	DISO 456 462	anemia
#9	AnnotatorNotes T9	C0002871; Anemia; Disease or Syndrome
T10	ANAT 513 527	cardiovascular
#10	AnnotatorNotes T10	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T11	ANAT 528 539	ventricular
#11	AnnotatorNotes T11	C0018827; Heart Ventricle; Body Part, Organ, or Organ Component | C1280934; Entire cardiac ventricle; Body Part, Organ, or Organ Component
T12	DISO 556 559	ERC
#12	AnnotatorNotes T12	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T13	PROC 609 691	ensayo clínico abierto, no controlado, no aleatorizado, multicéntrico, prospectivo
#13	AnnotatorNotes T13	C0681868; Uncontrolled Study; Research Activity + C1709323; Open Label Study; Research Activity + C1096776; Multicenter Study; Research Activity + C0033522; Prospective Studies; Research Activity + C2985410; Nonrandomized; Research Activity
T14	PROC 693 704	seguimiento
#14	AnnotatorNotes T14	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T15	PROC 727 738	seguimiento
#15	AnnotatorNotes T15	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T16	PROC 769 798	Tasa de Filtración Glomerular
#16	AnnotatorNotes T16	C0017654; Glomerular Filtration Rate; Diagnostic procedure
T17	PROC 829 844	ecocardiografía
#17	AnnotatorNotes T17	C0013516; Echocardiography; Diagnostic Procedure
T18	PROC 886 897	seguimiento
#18	AnnotatorNotes T18	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T19	DISO 933 936	HVI
#19	AnnotatorNotes T19	C0149721; Left Ventricular Hypertrophy; Disease or Syndrome
T20	PROC 994 1005	hematócrito
#20	AnnotatorNotes T20	C0018935; Hematocrit procedure; Laboratory Procedure
T21	PROC 1120 1123	eco
#21	AnnotatorNotes T21	C0041618; Ultrasonography; Diagnostic Procedure
T22	DISO 1148 1151	HVI
#22	AnnotatorNotes T22	C0149721; Left Ventricular Hypertrophy; Disease or Syndrome
T23	DISO 1265 1268	HVI
#23	AnnotatorNotes T23	C0149721; Left Ventricular Hypertrophy; Disease or Syndrome
T24	PROC 463 470	tratada
#24	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	DISO 1343 1353	daño renal
#25	AnnotatorNotes T25	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome (?)
T26	DISO 1391 1401	diabéticos
#26	AnnotatorNotes T26	C0011849; Diabetes Mellitus; Disease or Syndrome | C0241863; Diabetic; Finding | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T27	DISO 1466 1476	diabéticos
#27	AnnotatorNotes T27	C0011849; Diabetes Mellitus; Disease or Syndrome | C0241863; Diabetic; Finding | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T28	DISO 1574 1588	evento adverso
#28	AnnotatorNotes T28	C0877248; Adverse event; Pathologic Function
T29	PROC 1617 1629	hemodiálisis
#29	AnnotatorNotes T29	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T30	PROC 1641 1652	seguimiento
#30	AnnotatorNotes T30	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T31	DISO 1853 1856	ERC
#31	AnnotatorNotes T31	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T32	DISO 1823 1835	anemia renal
#32	AnnotatorNotes T32	C1142276; Renal anemia; Disease or Syndrome
T33	DISO 1888 1891	HVI
#33	AnnotatorNotes T33	C0149721; Left Ventricular Hypertrophy; Disease or Syndrome
T34	DISO 1911 1916	daños
#34	AnnotatorNotes T34	C0684336; Impaired health; Finding
T35	PROC 1939 1950	tratamiento
#35	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	DISO 1957 1963	anemia
#36	AnnotatorNotes T36	C0002871; Anemia; Disease or Syndrome
T37	ANAT 65 76	ventricular
#37	AnnotatorNotes T37	C0018827; Heart Ventricle; Body Part, Organ, or Organ Component | C1280934; Entire cardiac ventricle; Body Part, Organ, or Organ Component
T38	ANAT 152 157	renal
#38	AnnotatorNotes T38	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T39	ANAT 188 193	renal
#39	AnnotatorNotes T39	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T40	CHEM 243 277	eritropoyetina recombinante humana
#40	AnnotatorNotes T40	C0376541; Recombinant Erythropoietin; Amino Acid, Peptide, or Protein · Pharmacologic Substance (?)
T41	CHEM 475 481	EPOrHu
#41	AnnotatorNotes T41	C0376541; Recombinant Erythropoietin; Amino Acid, Peptide, or Protein · Pharmacologic Substance (?)
T42	PROC 1288 1299	hemoglobina
#42	AnnotatorNotes T42	C0518015; Hemoglobin measurement; Laboratory Procedure
T43	ANAT 1348 1353	renal
#43	AnnotatorNotes T43	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T44	DISO 1598 1606	falleció
#44	AnnotatorNotes T44	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T45	ANAT 1830 1835	renal
#45	AnnotatorNotes T45	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T46	DISO 120 123	ERC
#46	AnnotatorNotes T46	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T47	DISO 212 215	ERC
#47	AnnotatorNotes T47	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T48	PROC 818 822	MDRD
#48	AnnotatorNotes T48	C1980036; Creatinine-based formula (MDRD); Laboratory Procedure
T49	DISO 1684 1686	EA
#49	AnnotatorNotes T49	C0002395; Alzheimer's Disease; Disease or Syndrome
T50	CHEM 1864 1870	EPOrHu
#50	AnnotatorNotes T50	C0376541; Recombinant Erythropoietin; Amino Acid, Peptide, or Protein · Pharmacologic Substance (?)
T51	CHEM 1975 1981	EPOrHU
#51	AnnotatorNotes T51	C0376541; Recombinant Erythropoietin; Amino Acid, Peptide, or Protein · Pharmacologic Substance (?)
T53	Duration 194 201	crónica
#52	AnnotatorNotes T53	C0205191; chronic; Temporal Concept
T56	Duration 713 723	56 semanas
T57	Duration 923 926	año
T58	LIVB 1019 1028	pacientes
#53	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T61	LIVB 1381 1390	pacientes
#54	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	Neg_cue 1463 1465	no
T63	LIVB 1538 1547	pacientes
#55	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	Neg_cue 1590 1597	ninguno
T66	LIVB 1839 1848	pacientes
#56	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	Neg_cue 1892 1895	sin
T52	PHYS 380 399	funciones cardíacas
#57	AnnotatorNotes T52	C0232164; Cardiac function; Organ or Tissue Function
T54	PHYS 505 527	función cardiovascular
#58	AnnotatorNotes T54	C0678859; cardiovascular system function; Organ or Tissue Function
T55	PHYS 777 798	Filtración Glomerular
#59	AnnotatorNotes T55	C0232809; Glomerular filtration; Organ or Tissue Function
T59	ANAT 788 798	Glomerular
#60	AnnotatorNotes T59	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Assertion T27 Negated
A2	Assertion T44 Negated
A3	Assertion T29 Negated
A4	Assertion T34 Negated
R1	Used_for Arg1:T2 Arg2:T1	
R2	Location_of Arg1:T37 Arg2:T3	
R3	Location_of Arg1:T39 Arg2:T5	
R4	Has_Duration_or_Interval Arg1:T5 Arg2:T53	
T60	Quantifier_or_Qualifier 124 126	3b
R5	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T60	
T65	Quantifier_or_Qualifier 560 564	3b-4
R6	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T65	
T68	Quantifier_or_Qualifier 1857 1859	3b
R7	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T68	
R8	Location_of Arg1:T43 Arg2:T25	
R9	Experiences Arg1:T61 Arg2:T26	
R10	Negation Arg1:T67 Arg2:T34	
T69	CONC 89 113	balance beneficio riesgo
#61	AnnotatorNotes T69	C0687742; Risks and Benefits; Qualitative Concept
T70	Quantifier_or_Qualifier 216 220	3b-4
R11	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T70	
T71	Quantifier_or_Qualifier 202 210	avanzada
R12	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T71	
R13	Location_of Arg1:T38 Arg2:T4	
R14	Overlap Arg1:T4 Arg2:T5	
R15	Overlap Arg1:T4 Arg2:T47	
R16	Used_for Arg1:T40 Arg2:T6	
R17	Location_of Arg1:T8 Arg2:T52	
R18	Used_for Arg1:T41 Arg2:T24	
R19	Location_of Arg1:T10 Arg2:T54	
R20	Location_of Arg1:T11 Arg2:T54	
T72	Quantifier_or_Qualifier 540 549	izquierda
#62	AnnotatorNotes T72	C0205091; Left; Spatial Concept
R21	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T72	
T74	CONC 570 586	riesgo beneficio
#64	AnnotatorNotes T74	C0687742; Risks and Benefits; Qualitative Concept
R23	Overlap Arg1:T9 Arg2:T12	
R26	Has_Duration_or_Interval Arg1:T14 Arg2:T56	
R27	Has_Duration_or_Interval Arg1:T15 Arg2:T56	
R28	Location_of Arg1:T59 Arg2:T55	
T76	CONC 860 871	nivel basal
#66	AnnotatorNotes T76	C1442488; Baseline; Quantitative Concept
R29	Overlap Arg1:T16 Arg2:T76	
T77	CONC 876 897	final del seguimiento
R30	Overlap Arg1:T16 Arg2:T77	
R31	Overlap Arg1:T48 Arg2:T76	
R32	Overlap Arg1:T48 Arg2:T77	
R33	Overlap Arg1:T17 Arg2:T76	
R34	Overlap Arg1:T17 Arg2:T77	
R35	After Arg1:T19 Arg2:T57	
R36	Overlap Arg1:T16 Arg2:T57	
R37	Overlap Arg1:T48 Arg2:T57	
R38	Overlap Arg1:T17 Arg2:T57	
R39	Has_Duration_or_Interval Arg1:T18 Arg2:T57	
R40	Experiences Arg1:T58 Arg2:T20	
T78	Observation 965 975;990 1005	incremento del hematócrito
#67	AnnotatorNotes T78	C0239935; Hematocrit increased; Finding
R41	Experiences Arg1:T58 Arg2:T78	
T79	CONC 1032 1049	final del estudio
#68	AnnotatorNotes T79	C2983670; Study End Date; Temporal Concept
R42	Overlap Arg1:T78 Arg2:T79	
R43	Overlap Arg1:T20 Arg2:T79	
T80	CONC 1099 1107	Wilcoxon
#69	AnnotatorNotes T80	C0242931; Wilcoxon Rank Test; Quantitative Concept
T81	Quantifier_or_Qualifier 1124 1131	inicial
#70	AnnotatorNotes T81	C0439659; Beginning; Temporal Concept
R44	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T81	
T82	Quantifier_or_Qualifier 1157 1162	final
#71	AnnotatorNotes T82	C3853528; Final; Temporal Concept
R46	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T82	
T83	CONC 1229 1240	correlación
#72	AnnotatorNotes T83	C1707520; Correlation; Qualitative Concept
T84	Quantifier_or_Qualifier 1241 1255	inversa lineal
R47	Has_Quantifier_or_Qualifier Arg1:T83 Arg2:T84	
T85	Observation 1328 1353	progresión del daño renal
T86	Quantifier_or_Qualifier 1358 1363	lenta
#73	AnnotatorNotes T86	C0439834; Slow; Qualitative Concept
R52	Has_Quantifier_or_Qualifier Arg1:T85 Arg2:T86	
T87	CONC 1438 1446	Wilcoxon
#74	AnnotatorNotes T87	C0242931; Wilcoxon Rank Test; Quantitative Concept
R53	Negation Arg1:T62 Arg2:T27	
R54	Experiences Arg1:T61 Arg2:T27	
T88	CONC 1504 1512	Wilcoxon
#75	AnnotatorNotes T88	C0242931; Wilcoxon Rank Test; Quantitative Concept
R55	Experiences Arg1:T63 Arg2:T28	
R56	Negation Arg1:T64 Arg2:T44	
R57	Experiences Arg1:T63 Arg2:T44	
R58	Experiences Arg1:T63 Arg2:T29	
R59	Negation Arg1:T64 Arg2:T29	
R60	Overlap Arg1:T29 Arg2:T30	
R61	Overlap Arg1:T44 Arg2:T30	
R62	Overlap Arg1:T28 Arg2:T30	
T89	CONC 1657 1682	Balance Beneficio- Riesgo
#76	AnnotatorNotes T89	C0687742; Risks and Benefits; Qualitative Concept
T90	Quantifier_or_Qualifier 1687 1696	moderados
R63	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T90	
T91	Quantifier_or_Qualifier 1699 1705	graves
#77	AnnotatorNotes T91	C1547227; Severe - Severity of Illness Code; Intellectual Product
R64	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T91	
T92	CONC 1724 1751	cálculo del Factor de Bayes
R65	Location_of Arg1:T45 Arg2:T32	
R66	Experiences Arg1:T66 Arg2:T32	
R67	Overlap Arg1:T32 Arg2:T31	
R68	Experiences Arg1:T66 Arg2:T31	
R69	Experiences Arg1:T66 Arg2:T50	
R70	Before Arg1:T33 Arg2:T34	
R71	Experiences Arg1:T66 Arg2:T33	
R72	Experiences Arg1:T66 Arg2:T34	
R73	Used_for Arg1:T51 Arg2:T35	
T93	Quantifier_or_Qualifier 1964 1970	severa
#78	AnnotatorNotes T93	C1547227; Severe - Severity of Illness Code; Intellectual Product
R74	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T93	
R77	Overlap Arg1:T3 Arg2:T46	
R75	Overlap Arg1:T31 Arg2:T33	
T75	Quantifier_or_Qualifier 636 646	controlado
#65	AnnotatorNotes T75	C4553389; Study Control; Conceptual Entity
A5	Assertion T75 Negated
T94	Neg_cue 633 635	no
R24	Negation Arg1:T94 Arg2:T75	
T95	Neg_cue 648 650	no
T96	Quantifier_or_Qualifier 651 663	aleatorizado
A6	Assertion T96 Negated
R25	Negation Arg1:T95 Arg2:T96	
R76	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T96	
R78	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T75	
T97	Observation 358 369	repercusión
#79	AnnotatorNotes T97	C1518681; Outcome of Therapy; Finding (?)
R79	Causes Arg1:T6 Arg2:T97	
#63	AnnotatorNotes T71	C0205179; Advanced phase; Qualitative Concept
T73	Observation 442 449	mejoría
#80	AnnotatorNotes T73	C0184511; Improved; Finding (?)
R22	Causes Arg1:T24 Arg2:T73	
T98	Observation 1274 1281	mejoría
#81	AnnotatorNotes T98	C0184511; Improved; Finding (?)
R45	Location_of Arg1:T43 Arg2:T85	
#82	AnnotatorNotes T90	C0205081; Moderate (severity modifier); Qualitative Concept
A7	Experiencer T58 Patient
A8	Experiencer T61 Patient
A9	Experiencer T63 Patient
A10	Experiencer T66 Patient
R48	Has_Result_or_Value Arg1:T20 Arg2:T78	
